Drug: natalizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 12 Number of Pages: 1
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| NATALIZUMAB | Arteritis | 1 | view events |
| natalizumab | Drug hypersensitivity | 1 | view events |
| NATALIZUMAB | Eye pain | 1 | view events |
| NATALIZUMAB | Hemiparesis | 1 | view events |
| Natalizumab | Hepatosplenic T-cell lymphoma | 1 | view events |
| natalizumab | Infusion related reaction | 1 | view events |
| NATALIZUMAB | Keratic precipitates | 1 | view events |
| NATALIZUMAB | Necrotising retinitis | 1 | view events |
| NATALIZUMAB | Retinal haemorrhage | 1 | view events |
| NATALIZUMAB | Retinitis | 1 | view events |
| NATALIZUMAB | Vision blurred | 1 | view events |
| NATALIZUMAB | Vitritis | 1 | view events |
Total Drug/Injury Combinations: 12 Number of Pages: 1
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)